Longboard Pharmaceuticals, Inc. (LBPH)
Dec 2, 2024 - LBPH was delisted (reason: acquired by Lundbeck)
59.98
0.00 (0.00%)
Inactive · Last trade price on Nov 29, 2024
Longboard Pharmaceuticals Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Longboard Pharmaceuticals stock had an average target of $52.29, with a low estimate of $32 and a high estimate of $60.
Price Target: $52.29 (-12.82%)
Analyst Consensus: Buy
No price target forecast data available
Analyst Ratings
The average analyst rating for Longboard Pharmaceuticals stock from 8 stock analysts was "Buy". This means that analysts believed this stock was likely to outperform the market over the next twelve months.
Recommendation Trends
No data available
| Rating | Oct 2026 |
|---|---|
| Strong Buy | n/a |
| Buy | n/a |
| Hold | n/a |
| Sell | n/a |
| Strong Sell | n/a |
| Total | n/a |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.27
from -2.39
EPS Next Year
-2.88
from -2.27
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||
| Avg | n/a | n/a | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -2.18 | -2.63 | ||||
| Avg | -2.27 | -2.88 | ||||
| Low | -2.23 | -3.06 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |